These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22465172)

  • 1. Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?
    Becker RE; Greig NH
    Alzheimers Dement; 2013 Jan; 9(1):50-7. PubMed ID: 22465172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Was phenserine a failure or were investigators mislead by methods?
    Becker RE; Greig NH
    Curr Alzheimer Res; 2012 Dec; 9(10):1174-81. PubMed ID: 23227991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.
    Becker RE; Greig NH; Lahiri DK; Bledsoe J; Majercik S; Ballard C; Aarsland D; Schneider LS; Flanagan D; Govindarajan R; Sano M; Ferrucci L; Kapogiannis D
    Curr Alzheimer Res; 2018; 15(9):883-891. PubMed ID: 29318971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.
    Greig NH; Sambamurti K; Yu QS; Brossi A; Bruinsma GB; Lahiri DK
    Curr Alzheimer Res; 2005 Jul; 2(3):281-90. PubMed ID: 15974893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenserine Axonyx.
    Thatte U
    Curr Opin Investig Drugs; 2005 Jul; 6(7):729-39. PubMed ID: 16044670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenserine efficacy in Alzheimer's disease.
    Winblad B; Giacobini E; Frölich L; Friedhoff LT; Bruinsma G; Becker RE; Greig NH
    J Alzheimers Dis; 2010; 22(4):1201-8. PubMed ID: 20930279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease.
    Greig NH; Pei XF; Soncrant TT; Ingram DK; Brossi A
    Med Res Rev; 1995 Jan; 15(1):3-31. PubMed ID: 7898167
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of (+)-phenserine using an interrupted Fischer indolization reaction.
    Schammel AW; Chiou G; Garg NK
    J Org Chem; 2012 Jan; 77(1):725-8. PubMed ID: 22098120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
    Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.
    Shaw KT; Utsuki T; Rogers J; Yu QS; Sambamurti K; Brossi A; Ge YW; Lahiri DK; Greig NH
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7605-10. PubMed ID: 11404470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.
    Lilja AM; Luo Y; Yu QS; Röjdner J; Li Y; Marini AM; Marutle A; Nordberg A; Greig NH
    PLoS One; 2013; 8(1):e54887. PubMed ID: 23382994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenserine, a novel acetylcholinesterase inhibitor, attenuates impaired learning of rats in a 14-unit T-maze induced by blockade of the N-methyl-D-aspartate receptor.
    Patel N; Spangler EL; Greig NH; Yu QS; Ingram DK; Meyer RC
    Neuroreport; 1998 Jan; 9(1):171-6. PubMed ID: 9592071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why so few drugs for Alzheimer's disease? Are methods failing drugs?
    Becker RE; Greig NH
    Curr Alzheimer Res; 2010 Nov; 7(7):642-51. PubMed ID: 20704560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.
    Greig NH; De Micheli E; Holloway HW; Yu QS; Utsuki T; Perry TA; Brossi A; Ingram DK; Deutsch J; Lahiri DK; Soncrant TT
    Acta Neurol Scand Suppl; 2000; 176():74-84. PubMed ID: 11261809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.
    Kadir A; Andreasen N; Almkvist O; Wall A; Forsberg A; Engler H; Hagman G; Lärksäter M; Winblad B; Zetterberg H; Blennow K; Långström B; Nordberg A
    Ann Neurol; 2008 May; 63(5):621-31. PubMed ID: 18300284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenserine.
    Klein J
    Expert Opin Investig Drugs; 2007 Jul; 16(7):1087-97. PubMed ID: 17594192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physostigmine for Alzheimer's disease.
    Coelho F; Birks J
    Cochrane Database Syst Rev; 2001; 2001(2):CD001499. PubMed ID: 11405996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine.
    Hoffer BJ; Pick CG; Hoffer ME; Becker RE; Chiang YH; Greig NH
    J Biomed Sci; 2017 Sep; 24(1):71. PubMed ID: 28886718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs.
    Araujo JA; Greig NH; Ingram DK; Sandin J; de Rivera C; Milgram NW
    J Alzheimers Dis; 2011; 26(1):143-55. PubMed ID: 21593569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.